Insanabilis Research Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $460M
Latest Deal Amount

Insanabilis Research General Information

Description

Developer of medically innovative therapies designed to treat serious diseases with limited treatment options.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Excellence Health
Primary Office
  • 548 Market Street
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Insanabilis Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Jul-2017 $460M 00000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Insanabilis Research’s complete valuation and funding history, request access »